Please use this identifier to cite or link to this item: https://doi.org/10.1111/pace.14486
Title: Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech)
Authors: Lin, Weiqin 
Yip, Alfred Chung Lum
Evangelista, Lauren Kay Mance
Wong, Raymond Ching Chiew
Tan, Huay Cheem 
Lim, Toon Wei 
Singh, Devinder 
Keywords: Science & Technology
Life Sciences & Biomedicine
Technology
Cardiac & Cardiovascular Systems
Engineering, Biomedical
Cardiovascular System & Cardiology
Engineering
acute myocarditis
COVID-19
mRNA vaccine
ventricular tachycardiac
Issue Date: 4-Apr-2022
Publisher: WILEY
Citation: Lin, Weiqin, Yip, Alfred Chung Lum, Evangelista, Lauren Kay Mance, Wong, Raymond Ching Chiew, Tan, Huay Cheem, Lim, Toon Wei, Singh, Devinder (2022-04-04). Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech). PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. ScholarBank@NUS Repository. https://doi.org/10.1111/pace.14486
Abstract: To combat the coronavirus disease 2019 (COVID-19) pandemic, many countries have started population vaccination programs using messenger ribonucleic acid (mRNA) vaccines. With the widespread use of such vaccines, reports are emerging worldwide, of the vaccine's association with the development of myocarditis. Younger men are more likely to develop postvaccine myocarditis, which usually presents as self-limiting chest pain within a week after the second dose. We present a case of myocarditis following vaccination with tozinameran (BNT162b2, Pfizer-BioNTech), which presented late, with ventricular tachycardia (VT) reduced left ventricular ejection fraction (LVEF).
Source Title: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
URI: https://scholarbank.nus.edu.sg/handle/10635/228513
ISSN: 0147-8389
1540-8159
DOI: 10.1111/pace.14486
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech).pdf1.59 MBAdobe PDF

CLOSED

None

SCOPUSTM   
Citations

1
checked on Jan 26, 2023

Page view(s)

59
checked on Jan 26, 2023

Download(s)

2
checked on Jan 26, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.